| 000 | 01146 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250518010945.0 | ||
| 264 | 0 | _c20191119 | |
| 008 | 201911s 0 0 eng d | ||
| 022 | _a1557-3265 | ||
| 024 | 7 |
_a10.1158/1078-0432.CCR-18-3328 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGeyer, Mark B | |
| 245 | 0 | 0 |
_aFirst CAR to Pass the Road Test: Tisagenlecleucel's Drive to FDA Approval. _h[electronic resource] |
| 260 |
_bClinical cancer research : an official journal of the American Association for Cancer Research _c02 2019 |
||
| 300 |
_a1133-1135 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Comment | ||
| 650 | 0 | 4 | _aB-Lymphocytes |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunotherapy, Adoptive |
| 650 | 0 | 4 | _aPrecursor Cell Lymphoblastic Leukemia-Lymphoma |
| 650 | 0 | 4 | _aReceptors, Antigen, T-Cell |
| 773 | 0 |
_tClinical cancer research : an official journal of the American Association for Cancer Research _gvol. 25 _gno. 4 _gp. 1133-1135 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/1078-0432.CCR-18-3328 _zAvailable from publisher's website |
| 999 |
_c29078419 _d29078419 |
||